New fibroblast activation protein inhibitor, CPD60, attenuates fibrosis and chronic liver disease progresion in CCL4 induced liver fibrosis, but not in MDR2-/- mice

被引：0

作者：

Yang, Ai Ting ^{[1
,2
,3
]}

Kim, Yong Ook ^{[2
,3
]}

Aslam, Misbah ^{[2
,3
]}

Giardino, Mariacristina ^{[2
,3
]}

Abe, Hiroyuki ^{[2
,3
]}

Park, Kyoung Sook ^{[2
,3
]}

Khan, Muhammad Ashfaq ^{[2
,3
]}

You, Hong ^{[1
]}

Jia, Ji Dong ^{[1
]}

Klein, Thomas ^{[4
]}

Schuppan, Detlef ^{[2
,3
,5
]}

机构：

[1] Capital Med Univ, Beijing Friendship Hosp, Expt & Translat Res Ctr, Beijing, Peoples R China

[2] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Translat Immunol, Mainz, Germany

[3] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Res Ctr Immunotherapy FZI, Mainz, Germany

[4] Boehringer Ingelheim GmbH & Co KG, Cardiometabol Res, Biberach, Germany

[5] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02115 USA

来源：

JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期

关键词：

D O I：

10.1016/S0618-8278(19)30384-6

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

THU-104

引用

页码：E206 / E206

页数：1

共 50 条

[21] HEDGEHOG PATHWAY INHIBITOR IS A SAFE AND EFFECTIVE TREATMENT FOR HEPATOCELLULAR CARCINOMA IN MDR2-/- MICE WITH CHRONIC LIVER DISEASE
Schroder, Vanessa T.
Rangwala, Fatima
Syn, Wing-Kin
Guy, Cynthia D.
Karaca, Gamze F.
Diehl, Anna Mae
HEPATOLOGY, 2010, 52 (04) : 1146A - 1146A
[22] Targeted disruption of TGF-B activation by an AVB1 integrin inhibitor significantly reduces liver fibrosis in CCl4 mice and Human NASH liver slices
Schaub, Johanna
Decaris, Martin
Reilly, Maureen
Lee, Gail
Martin, Shamra
Rao, Vickram
Chen, Chun
Rexhepaj, Meghi
Kotak, Perna
Hooi, Lisa
Leftheris, Katarina
Cha, Jake
Lepist, Irene
Andre, Patrick
Turner, Scott
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E57 - E58
[23] Anthocyanins isolated from blueberry ameliorates CCl4 induced liver fibrosis by modulation of oxidative stress, inflammation and stellate cell activation in mice
Sun, Jianchao
Wu, Yafeng
Long, Cuizhen
He, Ping
Gu, Junying
Yang, Lei
Liang, Yaodong
Wang, Yuping
FOOD AND CHEMICAL TOXICOLOGY, 2018, 120 : 491 - 499
[24] PHARMACOLOGICAL EFFECTS OF ACETYL SALICYLIC ACID, SULFASALAZINE, IBUPROFEN AND CELECOXIB ON LIVER FIBROSIS INDUCED BY CHRONIC ADMINISTRATION OF CCL4
Chavez, E.
Moreno, M. G.
Muriel, P.
JOURNAL OF HEPATOLOGY, 2009, 50 : S272 - S272
[25] Collagen-binding vascular endothelial growth factor attenuates CCl4-induced liver fibrosis in mice
Wu, Kangkang
Huang, Rui
Wu, Hongyan
Liu, Yong
Yang, Chenchen
Cao, Shufeng
Hou, Xianglin
Chen, Bing
Dai, Jianwu
Wu, Chao
MOLECULAR MEDICINE REPORTS, 2016, 14 (05) : 4680 - 4686
[26] The heat shock protein 90 inhibitor, 17-AAG, attenuates thioacetamide induced liver fibrosis in mice
Abu-Elsaad, Nashwa M.
Serrya, Marwa S.
El-Karef, Amr M.
Ibrahim, Tarek M.
PHARMACOLOGICAL REPORTS, 2016, 68 (02) : 275 - 282
[27] The heat shock protein 90 inhibitor, 17-AAG, attenuates thioacetamide induced liver fibrosis in mice
Nashwa M. Abu-Elsaad
Marwa S. Serrya
Amr M. El-Karef
Tarek M. Ibrahim
Pharmacological Reports, 2016, 68 : 275 - 282
[28] Resolvin D1 attenuates CCl4 Induced Liver Fibrosis by Inhibiting Autophagy-Mediated HSC activation via AKT/mTOR Pathway
Li, Jiahuan
Deng, Xiaoling
Wang, Shuhan
Jiang, Qianqian
Xu, Keshu
FRONTIERS IN PHARMACOLOGY, 2021, 12
[29] NOX1/4 Inhibition Attenuates Myofibroblast Activation and Liver Fibrosis in MDR2 Deficient Mice, a Model of Progressive Cholangiopathy
Nishio, Takahiro
Liang, Shuang
Mccubbin, Ryan
Kisseleva, Tatiana
Brenner, David A.
HEPATOLOGY, 2018, 68 : 642A - 643A
[30] GUT-DERIVED BACTERIAL PRODUCTS DRIVE PROGRESSION OF LIVER FIBROSIS IN MDR2-/- MICE: INVOLVEMENT OF LPS AND TLR4
Poelstra, Klaas
Popov, Yury
Sverdlov, Deanna Y.
Sharma, Anisha
Schuppan, Detlef
HEPATOLOGY, 2009, 50 (04) : 819A - 819A

← 1 2 3 4 5 →